Freddie Mac (FRE) is one sale at $.65. A day-trader’s dream, down from a 52-week high of $65.88.
Fannie Mae (FNM) Almost a better deal. Sells off to $.65 from 52-week high of $68.60.
Biodel (BIOD) Concerns over drug trial. Drops to $4.34 from $25.69.
Authentec (AUTH) Revises guidance. Plunges to $2.40 from 52-week high of $19.81.
Cell Genesys (CEGE) Still hurting a week after drug trial news. Slips to $.67 from 52-week high of $4.67.
Douglas A. McIntyre
